Bull & Bear

Figures converted from KZT at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Bull and Bear

Verdict: Lean Long, Wait For Confirmation — the franchise economics are real (51% ROE through an 18% base-rate cycle at 6% Cost of Risk, on 93% deposit funding) but the discount is anchored by an unresolved litigation binary plus the sharpest post-IPO momentum reversal in the file.

Bull wins narrowly on the durable variable: nothing else in the EM consumer-finance comp set prints these returns at this multiple, and the wide-moat readings (Payments + Fintech $1.51B of FY25 net income on deposit-funded spread) survive the FY25 headline reset. Bear wins on near-term timing: four consecutive quarters at a 54–60% group operating margin, a live US securities class action management has not addressed across seven CEO letters, and a $78 → $97 → $78 round-trip in six weeks that left distribution volume on the tape. The decisive tension is whether the FY25 operating-margin compression is the integration step-down or the new structural ceiling — Q2 or Q3 2026 will answer it. A confirmed lean requires both an op-margin print above 58% and a clarifying Krivenok docket event; without those, this is a watchlist with a long bias, not a position.

Bull Case

Bull's price target is $135 per ADS on 11x forward P/E applied to FY26 EPS of ~$12.28, over a 12–18 month horizon. The primary catalyst is consolidated operating margin printing above 58% in Q2 or Q3 2026 — the single metric that validates Hepsiburada is integrating on plan and that the FY25 55% margin was transitional. The disconfirming signal is Kaspi Payments take rate falling below 0.9% in any quarter (currently ~1.10% on $84.9B TPV) or NBK opening public consultation on PIX-style open-loop QR interoperability — either would commoditize the Payments rail and force a permanent ROE re-rate.

Bear Case

Bear's downside target is $58 per ADS (vs current $78) on a 5.5x bank-multiple compression to FY26E EPS of ~$10.65 (–7% vs FY25 $10.74, reflecting the +200 bps bank tax, no rate cuts, sustained Hepsiburada drag, and one quarter of take-rate compression), over a 12-month horizon. The primary trigger is a Q2 or Q3 2026 print where consolidated op margin lands at or below 52% and Hepsiburada misses the EBITDA-breakeven bar — that combination breaks the bull's "55% is the floor, Türkiye recovers" frame in the same release. The signal that would force a cover is a clean motion-to-dismiss with prejudice in Krivenok combined with confirmed Rabobank A.S. licence approval, or a single quarter of consolidated op margin above 58% with Hepsiburada printing positive EBITDA.

The Real Debate

Verdict

Lean Long, Wait For Confirmation. Bull carries more weight on the durable variable — a 51% ROE held through an NBK tightening cycle at 6.0% CoR on 93% deposit funding is the highest-confidence wide-moat read in this file, and 7.1x P/E vs 19.5x peer median is a real anchor-mismatch on the two engines (Payments + Fintech) that do not depend on rate cuts. The decisive tension is whether the 54–60% operating-margin band is the post-integration floor (bull) or the new structural ceiling (bear); Q2 or Q3 2026 prints the answer. The bear could still be right: Krivenok is genuinely binary, management has not addressed Culper across seven CEO letters, the FY26 +5% adj-EBITDA guide is set against permanent regulatory tightening, and the sharpest post-IPO momentum reversal came on rising volume. The verdict moves to a confirmed Lean Long only on a Q2 or Q3 op-margin print above 58% and a clarifying Krivenok docket event; it moves to Avoid if op margin prints at or below 52% with Hepsiburada missing EBITDA-breakeven, or if a Krivenok motion-to-dismiss is denied.